(Q53116575)

11 May 2018

title

Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. (English)

1 reference

11 May 2018

author name string

H Wada

1

1 reference

11 May 2018

J Thachil

2

1 reference

11 May 2018

M Di Nisio

3

1 reference

11 May 2018

P Mathew

4

1 reference

11 May 2018

S Kurosawa

5

1 reference

11 May 2018

S Gando

6

1 reference

11 May 2018

H K Kim

7

1 reference

11 May 2018

J D Nielsen

8

1 reference

11 May 2018

C-E Dempfle

9

1 reference

11 May 2018

M Levi

10

1 reference

11 May 2018

C-H Toh

11

1 reference

11 May 2018

The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis

12

1 reference

11 May 2018

publication date

4 February 2013

1 reference

11 May 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

11 May 2018

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

cites work

1 reference

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

21 January 2018

1 reference

Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

21 January 2018

1 reference

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria

21 January 2018

1 reference

Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation.

21 January 2018

1 reference

Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response

21 January 2018

1 reference

Disseminated intravascular coagulation: old disease, new hope

21 January 2018

1 reference

The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview

21 January 2018

1 reference

Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC.

21 January 2018

1 reference

21 January 2018

1 reference

Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries

21 January 2018

1 reference

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

21 January 2018

1 reference

Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases

21 January 2018

1 reference

Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation.

21 January 2018

1 reference

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

21 January 2018

1 reference

Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

21 January 2018

1 reference

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

21 January 2018

1 reference

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

21 January 2018

1 reference

Coagulation abnormalities in critically ill patients

21 January 2018

1 reference

Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin

21 January 2018

1 reference

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

21 January 2018

1 reference

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.

21 January 2018

1 reference

Prevention and treatment of major blood loss

21 January 2018

1 reference

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

21 January 2018

1 reference

All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia

21 January 2018

1 reference

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.12155

1 reference

11 May 2018

1 reference

11 May 2018